Journals / Eurasian Journal of Emergency Medicine / 2019 / Cilt: 18 - Sayı: 4

Steroid Injection Versus Open Surgery in the Treatment of De Quervain’s Tenosynovitis

Pages
173–177
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were no complications in both groups.Conclusion: Although steroid injection is a therapeutic option in De Quervain’s tenosynovitis, open surgery appears to be a more beneficialmethod with relatively low recurrence and complication rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aimed to compare steroid injection and open surgery in the treatment of De Quervain’s tenosynovitis.Materials and Methods: Between January 2013 and April 2015, a total of 82 patients (65 females, 17 males; mean age=40.3 years;range, 20 to 71 years) who were admitted were included retrospectively.
📊
Key Findings & Data:The rates of recurrence and satisfaction were evaluated.
💡
Conclusion & Impact:There were no complications in both groups.Conclusion: Although steroid injection is a therapeutic option in De Quervain’s tenosynovitis, open surgery appears to be a more beneficialmethod with relatively low recurrence and complication rates.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: This study aimed to compare steroid injection and open surgery in the treatment of De Quervain’s tenosynovitis.Materials and Methods: Between January 2013 and April 2015, a total of 82 patients (65 females, 17 males; mean age=40.3 years;range, 20 to 71 years) who were admitted were included retrospectively. The patients were assigned into two groups, including group Iundergoing open surgery, and group II receiving steroid injections. The rates of recurrence and satisfaction were evaluated. The patientsundergoing surgery were also evaluated for the wound site infection, nerve injury, wound opening, and limited range of motions of thejoints. The patients receiving steroid injections were evaluated for subcutaneous atrophy, fat necrosis, weakening or rupture of tendons,and depigmentation.Results: The mean follow-up was 12 months (range: 6 to 22). Recurrence occurred in eight patients (20%) in the steroid injection group;however, no recurrence was seen in patients undergoing open surgery. Satisfactory or very satisfactory results were achieved in all patientsin the surgery group (p=0.04). There were no complications in both groups.Conclusion: Although steroid injection is a therapeutic option in De Quervain’s tenosynovitis, open surgery appears to be a more beneficialmethod with relatively low recurrence and complication rates.

🔖

Cite This Article

MEMİK, R., ACAR, E. (2022). Steroid Injection Versus Open Surgery in the Treatment of De Quervain’s Tenosynovitis. Eurasian Journal of Emergency Medicine, Cilt: 18 - Sayı: 4, 173–177. https://ajindex.com/articles/508021

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. De Quervain F. On a form of chronic tendovaginitis by Dr. Fritz de Quervain in la Chaux-de-fonds. 1895. Am J Orthop. 1997;26:641-4
  2. Stein AH, Ramsey RH, Key Ja. Stenosing tendovaginitis at the radial styloid process (DeQuervain’s disease). AMA Arch Surg. 1951;63:216-28
  3. Oh JK, Messing S, Hyrien O, Hammert WC. Effectiveness of Corticosteroid Injections for Treatment of de Quervain’s Tenosynovitis. Hand (NY). 2017;12:357-61 4. Ilyas AM, Ast M, Schaffer AA, Thoder J. De quervain tenosynovitis of the wrist. J Am Acad Orthop Surg. 2007;15:757-64
  4. Akram M, Shahzad ML, Farooqi FM, Irshad M, Kumar Sah R, Awais SM. Results of injection corticosteroids in treatment of De Quervain’s Tenosynovitis. J Pak Med Assoc. 2014;64:30-3
  5. Richie CA, Briner WW Jr. Corticosteroid injection for treatment of de Quervain’s tenosynovitis: a pooled quantitative literature evaluation. J Am Board Fam Pract. 2003;16:102-6
  6. Wharton R, Thaya M, Eckersley R. The dangers of injecting blind: Abductor pollicis longus tendon rupture in de Quervain’s disease. J Hand Surg Eur Vol. 2015;40:322-3
  7. Moore JS. De Quervain’s tenosynovitis: Stenosing tenosynovitis of the first dorsal compartment. J Occup Environ Med. 1997;39:990-1002
  8. Lee ZH, Stranix JT, Anzai L, Sharma S. Surgical anatomy of the first extensor compartment: A systematic review and comparison of normal cadavers vs. De Quervain syndrome patients. J Plast Reconstr Aesthet Surg. 2017;70:127- 31
  9. Finkelstein H. Stenosing tendovaginitis at the radial styloid process. J Bone Jt Surg. 1930;12:509-40
  10. Kutsumi K, Amadio PC, Zhao C, Zobitz ME, Tanaka T, An KN. Finkelstein’s test: a biomechanical analysis. J Hand Surg Am. 2005;30:130-5
  11. Alexander RD, Catalano LW, Barron OA, Glickel SZ. The extensor pollicis brevis entrapment test in the treatment of de Quervain’s disease. J Hand Surg Am. 2002;27:813-6
  12. Kay NR. De Quervain’s disease: changing patology or changing perception? J Hand Surg Br. 2000;25:65-9
  13. Nagaoka M, Matsuzaki H, Suzuki T. Ultrasonographic examination of de Quervain’s disease. J Orthop Sci. 2000;5:96-9
  14. Kamel M, Moqhazy K, Eid H, Mansour R. Ultrasonographic diagnosis of de Quervain’s tenosynovitis. Ann Rheum Dis. 2002;61:1034-5
  15. Harvey FJ, Harvey PM, Horsey MW. De Quervain’s disease: Surgical or nonsurgical treatment. J Hand Surg Am. 1990;15:83-7
  16. Witt J, Pess G, Gelberman RH. Treatment of de Quervain tenosynovitis. A prospective study of the results of injection of steroids and